Keros Therapeutics, Inc.
USD10.55
-0.35 (-3.21%)
CEO
Jasbir S. Seehra
IPO Date
2020-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.96
Prev. Close
$10.90
Day Low
$10.49
Day High
$11.11
52W Low
$9.79
52W High
$22.55
Market Cap
$0.34B
Volume
0.31M
| 1,000 |
| $11.70 |
| 6 Apr 2026 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | Acquired | 55,000 | $0.30 |
| 6 Apr 2026 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | Disposed | 55,000 | $0.30 |
| 27 Mar 2026 | Cho Esther | Chief Legal Officer | A-Award | Acquired | 80,000 | $15.52 |
| 11 Mar 2026 | Newton Charles W. | director | A-Award | Acquired | 13,215 | $0.00 |
| 11 Mar 2026 | Newton Charles W. | director | A-Award | Acquired | 14,788 | $11.35 |
| 11 Mar 2026 | Newton Charles W. | — | Disposed | 0 | $0.00 |
| 11 Mar 2026 | BIENAIME JEAN JACQUES | director | P-Purchase | Acquired | 2,000 | $11.21 |
| 26 Feb 2026 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 217,000 | $15.52 |